Loading market dashboard
ORIC Pharmaceuticals, Inc.
ORICHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
ORIC Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $259.28M | $259.28M - $259.28M | $0.00 | -$0.443 | 7 |
| Dec 2029 | $73.16M | $73.16M - $73.16M | $0.00 | -$1.745 | 7 |
| Dec 2028 | $10.83M | $10.83M - $10.83M | $0.00 | -$1.623 | 8 |
| Dec 2027 | $2.21M | $2.21M - $2.21M | $0.00 | -$1.544 | 10 |
| Dec 2026 | $8.22M | $8.22M - $8.22M | $0.00 | -$1.451 | 11 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.517 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.852 | 0 |